Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100060592 | 10006059 | 2 | F | 20140318 | 20140313 | 20140331 | PER | IL-JNJFOC-20140306346 | JANSSEN | 86.00 | YR | M | Y | 0.00000 | 20140331 | N | MD | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100060592 | 10006059 | 1 | PS | XARELTO | 1 | ORAL | U | 0 | 15 | MG | TABLET | ||||||||
| 100060592 | 10006059 | 2 | SS | XARELTO | 1 | ORAL | U | 202439 | 15 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100060592 | 10006059 | 1 | Cerebrovascular accident prophylaxis |
| 100060592 | 10006059 | 2 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100060592 | 10006059 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100060592 | 10006059 | Erythema multiforme | |
| 100060592 | 10006059 | General physical health deterioration | |
| 100060592 | 10006059 | Local swelling | |
| 100060592 | 10006059 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |